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ABSTRACT
CAMILLA GRACE PUGLIA: THE ROLE OF THE AGE LIGAND AND RAP1A
IN MYOFIBROBLAST SIGNALING CASCADE IN TYPE 2 DIABETES
MELLITUS-INDUCED CARDIOMYOPATHIC CONDITIONS
Diabetes is one of the leading causes of death in the United States, taking
more than 90,000 lives annually. Type 2 diabetes mellitus-induced cardiac fibrosis is
a common condition seen in diabetic patients. The AGE/RAGE signaling cascade has
been strongly associated with this supposed cardiac fibrosis along with hyperactive
myofibroblasts which excessively remodel extracellular matrix tissue, leading to
damaged and enlarged heart muscle tissue. In diabetic patients, Advanced Glycation
End Products (AGEs) are produced in abundance and accumulate in the extracellular
matrix of heart tissue. To investigate the role of of the AGE ligand on fibroblast
behavior, increasing amounts of commercially available exogenous AGE were
introduced as a gradient to compare fibroblast cells of four genotypes: diabetic (db),
diabetic RAGE knockout (db RKO), Rap1a (Rap1a), Rap1a knockout (RAPKO).
Once the fibroblasts were grown to maturity, they were plated in either high or low
glucose growth media. The cell’s migration rates were analyzed by scratching the
cultured cells in the center of each well at 0 hours after ligand AGE was applied.
Using computer digital editing to mark their movement between 0 and 24 hours
across the scratched area after the ligand AGE was applied to the plate of cells, the
number of cells crossing or touching the drawn boundaries were then counted.
Results from this study estimated trends that could have significance on the effect of
hyperglycemia and AGE exposure. Additionally, changes in migration were seen to
be more dependent upon genotype rather than exposure conditions.
v
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CHAPTER ONE:
INTRODUCTION
Diabetes Mellitus: Type 1 & 2
Type 1 and 2 diabetes are both defined by improper signaling and cell
response to the hormone, insulin. Type 1 diabetes, otherwise known as “juvenile
diabetes” for its early age onset, results as β-cells in the pancreas fail to produce
insulin, which is the essential key for working body cells to uptake glucose. Type 2
diabetes, which will serve as the focus of this study, accounts for approximately 90%
of diabetic patient cases and occurs as a result of excess glucose from either diet or
endogenous body stores from peripheral cell metabolism of glucose (1). This
condition is known as “insulin resistance,” and is often accompanied by loss of
pancreatic β-cell function (1). Insulin and glucagon have a delicate inverse
relationship that controls proper liver and cellular metabolism of glucose. When
excess glucose is circulating through the body, ineffective insulin levels cannot
suppress hepatic glucose production, thus, will enhance gluconeogenesis and
glycogenolysis in the liver, resulting in even higher amount of glucose in the blood.
Hyperglycemia manifests in an amalgam of harmful manners for diabetic patients:
heart disease, nerve, kidney, eye, and even foot damage (1). Diabetes and its chronic
comorbidities account for millions of dollars in healthcare spending every year and
take quit the toll on its victims (2). Diabetes is one of the leading causes of death in
the United States every year, taking close to 90,000 lives. Also, heart pathologies are
twice as likely to affect those with diabetes (3). Type 2 diabetes mellitus-induced
1

cardiac fibrosis is a common condition seen in diabetic patients.
Cardiac fibrosis results from an accumulation of scar tissue from
hyperactivated myofibroblasts remodeling cardiac extracellular matrix (ECM).
Activated myofibroblasts will synthesize an abundance of ECM proteins, like
collagen type I, which will lead to an increased cardiac matrix stiffness and
abnormalities in cardiac function (4). Following a cardiac injury, the effected cells
are regenerated, and the spot of injury is replaced with scar tissue. In addition, ECM
remodeling and cross-linking play a crucial role in wound repair and resulting cardiac
fibrosis. The residual build-up of collagen affects the contractility and relaxation of
the heart muscle, leading to impaired functioning of the heart as stiffness accelerates
in proportion to the crosslink density (4).
In healthy cardiac tissues, there is a delicate alternation between ECM
synthesis and degradation by cardiac fibroblasts to maintain a stable cardiac
structure. Following heart failure or other cardiac injuries, this balance is disrupted.
Often, the remodeling is reparative, creating regions of scar tissue or depositing of
excess collagen in areas other than the original wound (5).
AGE/RAGE Signaling Cascade
Fibroblast activation and transition to a myofibroblast phenotype is a crucial
step in increased migration, collagen deposition, and increased matrix stiffness. This
transition is a result of activation of intracellular and extracellular signaling. The
ligand, advanced glycated end product (AGE) and its receptor (RAGE) has been
proven to catalyze this transition to fibrosis-creating myofibroblasts. AGE/RAGE
signaling plays an important role in ECM protein expression and accumulation (1, 6).
2

Those suffering from type 2 diabetes-associated hyperglycemia often provide the
ideal environment for the joining of AGEs and their substrates (i.e. collagens, ECM
proteins). AGEs work to remodel ECM surrounding cardiac tissue by
nonenzymatically reacting with ECM proteins to form Amadori compounds. These
products will eventually transition to permanently cross-linked AGEs (7). AGEs are
likely to accumulate in patients with hyperglycemia at a higher rate than those with a
normal blood glucose level. In these high glucose environments, the increase in AGE
concentration will stiffen the ECM by forming rigid protein-sugar crosslinks. The
remodeled cardiac matrix as a result of hyperglycemia is now much more susceptible
to cardiac dysfunction.
With the increased signaling of the AGE/RAGE cascade under chronic high
blood glucose levels comes an up-regulation of RAGE, which will force the cascade
into a positive feedback loop. As this cycle speeds up with increasing blood glucose
levels and AGE accumulation, fibrosis growth factors will escalate matrix collagen
deposition and ECM crosslinking. Upregulation of the AGE/RAGE signaling cascade
has been associated with development of cardiovascular pathological
conditions, such as left ventricular stiffness (6).

Rap1a Importance
Rap1a is another key puzzle piece in the AGE/RAGE signaling cascade.
Rap1a is a GTPase that is thought to modulate the signal transmitted by activated
receptor RAGE (8). Rap1a signaling from the extracellular to intracellular level affects
the cardiovascular development in many facets. Rap1a works by binding to cardiac
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effector proteins, allowing its signal to either initiate or repress a cascade of effects,
such as proliferation, cell adhesion, and cell migration within the cardiovascular tissue
(9).
GTPase Rap1a has been demonstrated to intersect the AGE/RAGE signaling
cascade to activate downstream effectors like ERK1/2 MAPK (extracellular signalrelated kinase 1/2 mitogen-activated protein kinase), NF-κB (nuclear factor kappa B)
and JNK (c-Jun N-terminal kinase) (6). All of which are associated with cell growth
and development. The suspected role of Rap1a as a facilitator in the AGE/RAGE
pathway involves Rap1a activating PKC-ζ to then activate the kinase, ERK1/2,
prompting collagen production, RAGE expression, and fibroblast differentiation (6).
This can be visualized in Figure 1. Activation of all of these mechanisms via
accelerated AGE/RAGE signaling under hyperglycemic conditions will contribute to
cardiac ECM remodeling, scar tissue accumulation, and stiffening. Moreover, there is
evidence to demonstrate Rap1a is a mediator in the AGE/ RAGE pathway, supporting
the transition from fibroblast to myofibroblast (6). Prior experiments testing Rap1a as
an independent variable will be discussed later in this chapter, prefacing Rap1a’s role
in the main experiment.
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Figure 1: The proposed mechanism of Rap1a in the AGE/RAGE signaling cascade.
Increased activation of Rap1a will result in up regulation of PKC-ζ, resulting in
matrix accumulation.

Fibroblast Migration
Cardiac fibroblasts not only make up a large portion of the cell population in
the human heart, but they also have structural and development roles (9). Notably,
cardiac fibroblasts are part of an injury response team that will be activated and begin
to proliferate to promote healing of a damaged area of the heart. However, if the
healing signal continues to propagate post-injury, along with cardiac fibroblast
activation, scaring events contributing to ventricular remodeling are likely to occur
(9). For example, following myocardial infarctions (MI), fibroblasts have been seen
5

to adopt a “proinflammatory phenotype” that actively secretes immune and growth
signals, like cytokines and chemokines. Later on, this phenotype will alternate to a
“proreparative phenotype” which will remodel the cardiac ECM to an extent of
scaring and fibrosis. Complications resulting from these actions by fibroblasts include
left ventricle stiffening with impaired mechano-electric coupling and reduced oxygen
and nutrient supply to myocardial cells (10).
There is much controversy as to whether hyperglycemic conditions cause
halting or propagation of migration. Also, the AGE/RAGE cascade’s involvement in
migration has been shown to inhibit fibroblast migration in both non-diabetic and
diabetic mice (11). The role of the AGE/RAGE pathway along with the role of Rap1a
will continue to be evaluated in this study by controlling the genetic makeup and
growth environment of cardiac fibroblasts.
Previous Experiments and Findings on the AGE/RAGE Cascade
Cardiac complications like myocardial fibrosis related to high blood glucose
typically include ECM remodeling by depositing of excess collagen from
myofibroblast-mediated matrix protein synthesis. Glucose circulating through the
body in higher amounts reacts with ECM proteins, such as collagen to form AGEs.
These AGE products will further stiffen the cardiac tissue of the heart by forming
restrictive cross-links with the excess deposited collagen. The formation of AGEs
under hyperglycemic conditions will also initiate a positive feedback effect on the
RAGE concentrations.
There is still much to be understood regarding the role of the AGE/RAGE
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signaling cascade in cardiovascular fibrosis; however, previous experiments have
demonstrated its contributions to vascular inflammation (6). In studies where the
AGE receptor was silenced, cell migration also increased (6). In diabetic patients,
activation of the AGE/RAGE pathway caused cell apoptosis, exacerbating plaque
buildup and hardening of the inner lining of crucial arteries (6). Moreover, silencing
RAGE in diabetic mice (db RKO) resulted in a less stiff and higher functioning heart
(6). In addition, the AGE/RAGE cascade has strong affiliations with the PKC-ζ
signaling cascades, which together propagate the ERK signal, initiating fibrotic
forming factors like ECM accumulation and cell proliferation (6).
Cardiac migration is a crucial aspect of cardiac recovery following an injury.
Cardiac fibroblasts have demonstrated the ability to differentiate into myofibroblasts
under inflammatory conditions. Chemical signals, such as cytokines and growth
factors, directed towards fibroblasts following a cardiac wound will result in
myofibroblast transition (5). Myofibroblasts are known to be highly mobile as well as
contain contractile proteins to contribute significantly to wound closure and healing
scars (5). Migration occurs as myofibroblasts move towards the site of the injury to
promote an inflammatory response (5). Thus, migration is an important measurable
property of myofibroblasts. As type 2 diabetes is strongly associated with
cardiovascular disease, the effect high blood sugar has on fibroblast migration has
long been a topic of conversation and controversy. Diabetic fibroblasts have been
thought to disable cell migration; however, other experiments show discrepancies in
this theory (11). To better understand the properties of fibroblast migration under
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hyperglycemic conditions along with the function of the AGE/RAGE cascade, a
study from the Stewart Lab in 2020 analyzed diabetic and non-diabetic fibroblast
migration in varying environmental conditions: diabetic, non-diabetic, plastic
collagen matrices from lab mice (11).. It was observed that the diabetic fibroblast,
despite the collagen it was tested on, always showed the greatest migration. In
addition, when RAGE was silenced (RAGE knockout, RKO), fibroblast migration
decreased significantly (11).
When Rap1a expression was tested in this study by the Stewart Lab, silencing
the Rap1a gene reduced RAGE expression (11). While attenuating the
AGE/RAGE cascade through Rap1a, far less collagen production was a result.
Further, the Rap1a knockout (Rap1a KO) extracted mice hearts showed far less
collagen expression than the Rap1a Wild Type (Rap1a WT) control group (11). Also,
Rap1a knockout (Rap1a KO) cardiac fibroblasts demonstrated far less migration than
their control group, Rap1a Wild Type (Rap1a WT) (11). There was a strong
correlation between migration rates of Rap1a KO fibroblasts and non-diabetic RKO,
indicating the proposed relationship of Rap1a as a mediator to the AGE/RAGE
signaling cascade (11). Looking specifically at cardiac fibroblast with attenuated
RAGE function on diabetic collagen, migration was increased as RAGE expression
was progressively dampened (11). Furthermore, the increased amount of AGEs
resulting naturally from the hyperglycemic diabetic collagen matrix did not affect
fibroblast migration significantly (11). As the AGE concentration inevitably
increased from plastic to diabetic collagen, migration in nondiabetic fibroblasts
increased in small increments, while diabetic fibroblasts did not change (11). On the
8

other hand, both nondiabetic RKO and diabetic RKO fibroblast migration showed
similar rates of migration over the varying collagen types. Rap1a WT and Rap1a KO
fibroblasts exhibited this same behavior (11).
Exogenous, or lab-manufactured, AGEs were tested, as abundant AGE
concentrations can cause cross-linking in the ECM, as well as increased stiffness.
When exogenous AGE concentrations were increased on diabetic collagen,
nondiabetic and diabetic fibroblasts showed a significant increase in migration,
while RKO fibroblasts did not change migration patterns dramatically. Rap1a WT
and KO fibroblasts both demonstrated greater numbers of migrated cells/% area.
Evidence from this experiment contribute to the idea that excess AGE initiates a
transition in fibroblasts to myofibroblasts which are known for their greater mobility
(11). Thus, activation of the AGE/RAGE pathway could be linked to myofibroblast
differentiation along with heightened α-SMA collagen factor expression. Further
investigation must be executed on this relationship between aggressive AGE/RAGE
signaling and migrating cells.
The Stewart Lab took a closer look beyond the protein expression associated
with Rap1a mediation to examine its effect on fibroblast function. Specifically,
cardiac fibroblast contraction as a function of the AGE/RAGE cascade was studied.
Cardiac fibroblasts of varying genotypes were measured for matrix contraction,
protein expression (α-SMA, SOD-1, and SOD-2), and inflammatory response via
hydrogen peroxide production, all features of myofibroblast differentiation. As
previously mentioned, AGE/RAGE signaling can be a catalyst for myofibroblast
activation, and it has been linked to the up regulation of intracellular signals like
9

protein kinase C (PKC) and NADPH oxidase, culminating in reactive oxygen species
(ROS) like hydrogen peroxide (8). To test the role of Rap1a as a mediator in the
AGE/ RAGE response, exogenous AGEs were added to fully stimulate this response.
This recent study by the Stewart Lab determined that the AGE/ RAGE cascade was
influenced by Rap1a signaling, as increased AGE addition resulted in myofibroblast
differentiation marked by oxidative stress and matrix contraction (8).
The goal of this study was to determine if the combination of high glucose
exposure and increased exogenous AGEs impacted fibroblast migration, which is a
functional measurement of increased myofibroblast phenotype differentiation.
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CHAPTER TWO:
METHODS AND
MATERIALS
Animal Models
These experiments utilized type 2 diabetic Male Leprdb (db/db model; BKS
Cg- DOCKm +/+ Leprdb, Jackson Labs; JAX# 00642) mice at age four months of age.
Four genotypes were tested as independent variables: diabetic (db), diabetic RAGE
knockout (db RKO), Rap1a (Rap1a), Rap1a knockout (RAPKO). db mice were
generated by silencing the leptin receptor gene via point mutation. By 8 weeks of
age, the mice had developed hyperglycemia and overt diabetes at 12 weeks. Nondiabetic models were made up from a heterozygous genotype. RAGE was attenuated
(RKO model) using the “Cre-Lox recombinant technology” (8). Using two loxP
sites, the RAGE exons 2-7 were flanked in the same direction. In an opposite
orientation, an EGFP reporter gene inserted at intron 1, as well as a neomycin
cassette and thymidine kinase promoter. As a result of the flanking by the Cre
recombinase (Cre), the loxP regions were deleted, hindering mRNA production for
RAGE, thus, silencing RAGE expression (11). RAGE knockout non-diabetic (het
RKO) and diabetic RAGE knockout (db RKO) genotype were created by
crossbreeding non-diabetic (het) to RKO mice. Finally, to test the role of GTPase
Rap1a, the lan group silenced this gene by “insertion of a neomycin resistant gene
after exon 4 of RAP1A in the opposite (3’-5’) orientation. The resistance gene was
11

inserted via a 0.95 kb Pyull-Ndel fragment targeting vector” to prevent mRNA
production (11).
Animal Care
Mice in this experiment were utilized at 16 weeks of age and during that time
were maintained under the typical circadian rhythm, 12 h/12 h light/dark cycle). In
addition, mice were housed in a humane, commercial environment in the building of
Pharmaceutical Sciences on campus at the University of Mississippi. They were fed
mouse chow and drank tap water ad libitum (11). When mice reached maturity (16
weeks), they were received anesthesia in form of carbon dioxide inhalation prior to
humane euthanasia. The lab group then dislocated the spinal column from the skull and
brain of mice, causing disruption of blood vessels and nerve signals between these
structures and ultimately death to the mice (12). Following this, the mice were
immediately taken for heart extraction from which, the lab group was able to harvest
cardiac fibroblast cells for further experiments (11).
Fibroblast Isolation and Culture
Following mice euthanasia by carbon dioxide and cervical dislocation, they
were then weighed. Next, mice were dipped in 70% ethanol solution for sterilization
in preparation for heart dissection. Using a small, sharp knife, the end of each
mouse’s tail was cut and squeezed for blood glucose levels which were recorded
closely by use of diabetic test strips with blood glucose detectors (glucometer;
OneTouch®, LifeScan, Inc., Johnson & Johnson). The chest cavity was then gently
cut open using petite scissors with the skin pinned into the dissecting mat to keep the
mice in place while the heart was carefully extracted. It was then weighed and kept in
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cold 1X non-sterile PBS (phosphate buffered saline; 17mM NaCl, 0.3mM KCl,
1.01mM Na2HPO4, pH=7.4) on ice. During this process the lab group was diligent in
assuring the hearts were removed quickly after the mice were euthanized to ensure
that the heart cells were still highly viable.
The mice hearts were next used for fibroblast extraction in a sterile, laminar
flow hood, providing an aseptic environment for cell cultures by forcing constant air
flow to prevent dust or inevitable contaminants lingering in lab spaces (13). The
extracted hearts were reduced into small fragments to be placed in a 60mm petri dish
and washed three times with PBS solution. 5 mL of a collagenase-trypsin enzymatic
solution (0.1% Trypsin, Gibco; 100U/mL collagenase II, Worthington Biochemical)
was then mixed with the fractions of heart tissue. This heart tissue/enzyme
combination was stirred with a magnetic stir bar in a double-jacketed spinner flask at
37oC. This continued with proper water input until the heart cells formed a monolayer
(11). After 10 minutes of stirring, the mixture of tissues and enzymes was transferred
to a 50 mL conical tube by straining it through a cell filter. The conical tube now
contains the fluid connective tissue cell medium, and the heart tissue fragments caught
in the strainer were placed back in the spinner flask with an addition of 5 mL of
enzymatic solution. Next, “STOP” Dulbecco’s Modified Eagles Medium (DMEM)
[high glucose media; DMEM containing 4.5 g/L glucose, sodium pyruvate, Lglutamine, and supplemented with 14.2 mM NaHCO3 , 14.9 mM HEPES, 30% heatinactivated fetal bovine serum (FBS), 1% L- glutamine, and 0.02% Primocin™
(Thermo Fisher) was placed into the conical tube (11). This tube was then centrifuged
13

to allow a cell pellet to form at the bottom while the supernatant (fluid above solid
residue) was removed off the top and the pellet was placed in high-glucose DMEM
media containing 15% FBS. This culture was placed in an incubator for 24 hours and
then checked for attached fibroblasts. Attached fibroblasts were separated from
unattached through use of corresponding media three times and incubated at 37oC.
The isolation protocol continued until no heart tissue was caught in strainer. The
fibroblasts kept for isolation were kept in their appropriate at this point, and the lab
group observed their growth. At approximately 95% confluency (% of cultured
surface area covered by fibroblasts), the cells were transferred to 48-round well plates,
where only 28 wells were used. The media in these cell culture plates were exchanged
every other day. For the experimental purpose of this lab, the first 14 (A1-B7) wells
were kept in low glucose media and the last 14 (C1-D7) were kept in high glucose
media, Figure 2. This tray was kept in the incubator and observed by the lab group
until each well reached maximum fullness.
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Figure 2: Representative 48-well experimental set-up.
Migration Assay
Once the cells in the 48-well cell culture trays were grown to maximum
confluency (90-95%), a line with dashes was drawn down the diameter of the circular
wells to characterize the regions of the well for imaging. Then, using a 200 µL pipet
tip, each culture was scratched down the center of the well, following the drawn line.
Following physical scratching, each well was rinsed with 1x sterile PBS then
replenished with exactly 500 µL of appropriate media, either high or low glucose
media containing 1.5% FBS. Finally, the exogenous AGE was added the wells in
increments 0, 3.75, 7.5, 15, 30, 45, and 60µL in each row from well 1-7. The cell wells
were imaged at this point, “0 hours,” and the 48-well cell culture plate was returned to
15

the incubator for precisely 24 hours.

Imaging
As previously discussed, directly after cell wells were scratched down their
diameter and washed with 1x sterile PBS and resuspended in their respective medias,
two photos were captured under a Zeiss Primovert microscope camera (Zen Blue 2.3
edition, Zeiss): the upper half of the well and the lower half of the well. Immediately
following this 0 hour image, the tray was returned to the incubator for exactly 24
hours. The next day, in the sterile laminar flow hood, the tray was gently removed,
and respective medias were suctioned off and each well was rinsed with 1x sterile
PBS, then treated with 4% paraformaldehyde to fix the fibroblasts for 10 minutes at
20°C under a fume hood. The 4% PFA was then suctioned off and rinses carefully
again with 1x sterile PBS. Next, 1x PBS (0.1% Triton-100) was added to each well.
The triton solution functions to permeabilize the fibroblast cell membranes through
breaking up their lipid membrane bilayer to allow the cell markers to enter the cells
(14). The triton was left on the fibroblasts for around 30 minutes as the trays remained
on a BenchRocker that always the triton solution to work actively. After 30 minutes,
the 1x PBS-Trition-100 wash was suctioned off. The cells were then stained by
carefully pipetting 1% Brilliant Blue Coomassie solution into each well. This solution
was kept on the cells for 10 minutes on the BenchRocker again. Following this 10minute interval, the Brilliant Blue stain was suctioned off each well. The tray was
taken back to the Zeiss Primovert microscope for 24-hour images to be captured using
the microscope camera in intentional regions distinguished by the hash marks made
16

by the light-colored sharpie prior to scratching to align with the regions imaged at 0
hours.
Digital Migration Analysis
Once both the 0 and 24 images were captured for both the upper and lower
region of each cell well, the photos were uploaded onto Adobe Photoshop 2020. The 0hour photo was uploaded first, and lines were drawn on an extra layer to distinguish
where the original scratch down the diameter was made. The 24-hour picture was then
superimposed on top of the 0 hour photo. The hash marks made by the sharpie prior to
the first set of images allowed the images to be exactly aligned to analyze the proper
region. Now the lines denoting the scratch were made visible over the 24-hour image
and the stained, migrated fibroblasts that moved into the scratched regions could be
counted. Any fibroblast that visualized in the area made by the lines or touching the
lines was counted as a “migrated fibroblast.” Next, the area bound by the lines was
shaded all one color using photoshop and converted to greyscale. The image was then
saved, and the area of scratch was calculated using ImageJ software. An excel
document was used to keep track of each tray’s number of migrated cells and normalcy
(# migrated cells/area of scratched region) for each well’s two images. The entire
digital analysis process is demonstrated below in Figure 3.
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Step 1: Upload 0 hour image.

Step 2: Add a layer to the template &
draw lines outlining the scratched area
down the diameter using the pencil
feature.

Step 3: Add the corresponding 24 hour
image, superimposing it on the 0 hour
image to perfectly align.

Step 4: Delete the 0 hour image and place
the layer with the pencil linings over the
24 hour image.

Step 5: Count all of the fibroblasts that
touch the line or fall in between the two
lines.
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Step 6: Delete the 24 hour image all
together to leave the layer with the line
drawings only.

Step 7: Fill in the area between the 2 lines
to determine area of the space.

Step 8: Convert the image to grayscale
and move to ImageJ software to calculate
exact area.

Figure 3: The step-by-step guide to digital analysis using Photoshop 2020 & Image J
software
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CHAPTER THREE:
RESULTS
For each well, two images were captured to ensure every fibroblast was
accounted for. The well number, genotype, image number (1 or 2), number of
migrated fibroblasts, calculated area, and normalization (cells/area) were reported
for each image analyzed. The migrated cells for each of the two images per well
were then combined to one number. This number of migrated cells per well in either
high or low glucose media were next converted into a graphical point line analysis
subject-to-subject. Fibroblasts counted in the A1-B7 wells were averaged to form the
“LG” group 1-7 (low glucose conditions), and fibroblasts counted in the C1-D7
wells were averaged for the “HG” group 1-7 (high glucose conditions). Thus, A1
cells were averaged with B1 cells to account for well 1 of the LG group, and C1

cells were averaged with D1 cells to account for well 1 of the HG group, and so on
for the remaining wells 2-7. The y-axis represents the number of migrated cells in
the scratched area, and the x-axis represents the increasing AGE concentration.

Diabetic (db) Fibroblast Migration
Shown below are analyses of the entire regions for wells A1-7 (Low Glucose
Media) & B1-7 (Low Glucose Media) averaged Low Glucose Wells 1-7, C1-7 (High
Glucose Media) & D1-7 (High Glucose) Media averaged to High Glucose Wells 1-7
for trials 1, 2, 3 (n=1, 2, 3) of diabetic fibroblast analysis. It appeared diabetic cells
migrated better in high glucose media; however, increasing AGE concentrations did
not affect cell migration, Figures 4-6.
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Figure 4: Diabetic Subject #1, Number of Migrated Fibroblasts versus Well Number in
High Glucose and Low Glucose Growth Conditions

Figure 5: Diabetic Subject #2, Number of Migrated Fibroblasts versus Well Number in
High Glucose and Low Glucose Growth Conditions
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Figure 6: Diabetic Subject #3, Number of Migrated Fibroblasts versus Well Number in
High Glucose and Low Glucose Growth Conditions

Diabetic RAGE Knockout (dbRKO) Fibroblast Migration
Shown below are analyses of the entire regions for wells A1-7 (Low Glucose
Media) & B1-7 (Low Glucose Media) averaged to Low Glucose Wells 1-7, C1-7
(High Glucose Media) & D1-7 (High Glucose) Media averaged to High Glucose

Wells 1-7 for trials 1, 2, 3 (n=1, 2, 3) of RAGE knockout fibroblast analysis,
Figures 7-9. Overall, dbRKO fibroblasts had higher than other cell types, and these
changes were not altered by either AGE concentration or media glucose levels
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Figure 7: Diabetic RAGE Knockout Subject #1, Number of Migrated Fibroblasts versus
Well Number in High Glucose and Low Glucose Growth Conditions

Figure 8: Diabetic RAGE Knockout Subject #2, Number of Migrated Fibroblasts versus
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Well Number in High Glucose and Low Glucose Growth Conditions

Figure 9: Diabetic RAGE Knockout Subject #3, Number of Migrated Fibroblasts versus
Well Number in High Glucose and Low Glucose Growth Conditions
Analyzing the migration of diabetic (db) and diabetic RAGE knockout
(dbRKO) fibroblasts, it appears that the number of migrated cells was increased for
the cells that received high glucose media (wells C1-D7). There was not a very
consistent trend on cell migration in correlation exactly to AGE addition; however, ,
the number of migrated cells does appear to increase from control (0 µL) to
experimental values of AGE (7.5, 15, 30, 45, 60 µL). Finally, it appears that
Diabetic RAGE Knockout subject showed an overall great number of migrated cells.
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Rap1a Wild Type (RAPWT) Fibroblast Migration

Shown below are analyses of the entire regions for wells A1-7 (Low Glucose
Media) & B1-7 (Low Glucose Media) averaged Low Glucose Wells 1-7, C1-7 (High
Glucose Media) & D1-7 (High Glucose) Media averaged to High Glucose Wells 1-7
for trials 1, 2, 3 (n=1, 2, 3) of Rap1a Wild Type fibroblast analysis, Figures 10-12.

Figure 10: Rap1a Wild Type Subject #1, Number of Migrated Fibroblasts versus Well
Number in High Glucose and Low Glucose Growth Conditions
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Figure 11: Rap1a Wild Type Subject #2, Number of Migrated Fibroblasts versus Well
Number in High Glucose and Low Glucose Growth Conditions

Figure 12: Rap1a Wild Type Subject #3, Number of Migrated Fibroblasts versus Well
Number in High Glucose and Low Glucose Growth Conditions
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Overall, our findings suggested that neither glucose levels nor increasing

AGE concentrations will alter fibroblast migration in Rap1a WT cells.

Rap1a Knockout (RAPKO) Fibroblast Migration
Shown below are analyses of the entire regions for wells A1-7 (Low Glucose
Media) & B1-7 (Low Glucose Media) averaged Low Glucose Wells 1-7, C1-7 (High
Glucose Media) & D1-7 (High Glucose) Media averaged to High Glucose Wells 1-7
for trials 1, 2, 3 (n=1, 2, 3) of Rap1a Knockout fibroblast analysis, Figures 13-15.
Overall, our findings suggested that neither glucose levels nor increasing AGE
concentrations will alter fibroblast migration in Rap1a KO cells.

Figure 13: Rap1a Knockout Subject #1, Number of Migrated Fibroblasts versus
Well Number in High Glucose and Low Glucose Growth Conditions
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Figure 14: Rap1a Knockout Subject #2, Migrated Fibroblasts versus Well Number
in High Glucose and Low Glucose Growth Conditions

Figure 15: Rap1a Knockout Subject #3, Number of Migrated Fibroblasts versus
Well Number in High Glucose and Low Glucose Growth Conditions
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The Rap1aWT and Rap1aKO migration results demonstrated a few potential

trends to further investigate in the role of Rap1a in the AGE/RAGE signaling
cascade. Of note, when Rap1a expression was silenced in the Rap1a knockout
subjects, the number of migrated cells in the wells A1-B7 (low glucose media) tends
to stay more consistent with the number of migrated cells for wells C1-D7 (high
glucose media). There appeared to be a slight increase in migrated fibroblasts with
no functional Rap1a receptor, especially in the low glucose media. Another finding
to emphasize in this Rap1a experiment that parallels the previous study of diabetic
and diabetic RAGE knockout genotype subjects. In that, there was an increase in the
number of migrated cells as the media shifted from low glucose media (wells A1B7) to high glucose media (wells C1-D7).
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CHAPTER FOUR:
DISCUSSION & CONCLUSION
This study sought to further investigate the role of the AGE-mediated RAGE
signaling cascade, along with the effects varying growth mediums (high/low
glucose) has on cell migration. As steps of this experimental process were quite
detail-oriented, it is important to recognize the ease for error. Thus, there must be
more data through repetition collected in this study to be deemed a significant and
reliable. However, through the trials and processes taken in the endeavor, there were
many trends and correlations in terms of supposed myofibroblast differentiation and
migration to take note of.
For the fibroblast migration comparison across all four genotypes, the trends
to mention are the increases in migrated cells as glucose concentration in media
increased as well. There could be a true positive correlational relationship to pursue
between these two variables. This phenomenon can be observed in the graphical
analysis, where typically at the C1 well, there was a noticeable increase in migrated
cells that maintained at a rate higher than that from A1-B7. The question now

remains, what could this be attributed to? As previously discussed in a study from
2012, in diabetic or hyperglycemic conditions, AGEs tend to naturally accumulate as
glucose levels increase (15). With the added AGE concentration in the high glucose

media, it could possibly accelerate production of AGEs to react with their
counterpart, RAGE to instigate a reaction that causes inflammation, atherogenesis
and vasoconstriction along with myofibroblast transition, which would result in
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increased fibroblast migration. Thus, the high glucose media used in this study could

be fostering exacerbation of the AGE/RAGE signaling cascade, which would be
responsible for the marked spiked in migration.
Moreover, this trend goes hand-in-hand with another general finding in this
study: the average amount of migrated cells was higher from the control amount (0
µL) to experimental values of AGE (7.5, 15, 30, 45, 60 µL). The added presence of
AGEs added to the cell culture seems to act along the principles determined by the
Stewart Lab in 2020, where AGEs were thought to activate a shift in fibroblast
phenotype to a more migrant, inflammatory myofibroblast (11). This transition could
be attributed to the accelerated propagation of the AGE/RAGE signaling cascade
under hyperglycemic conditions. Also, in another study by the Stewart Lab in 2021,
it was observed that RAGE expression was greatly increased as a result of positive
feedback loop of the AGE/RAGE signal cascade (8). This feedback loop was found
to be accelerated by the input of exogenous AGEs in non-diabetic fibroblasts and
diabetic fibroblasts when compared to the AGE treated control (8).
When RAGE expression was silenced with the diabetic RAGE knockout
group, there was a slight increase in sheer number of migrated cells in the three trials
conducted in this study. In comparing the dbRKO subjects to the diabetic (db)

subject with a functional RAGE group, there appeared to be more migrated cells not
only in the high glucose media, but a slight increase cells in the low glucose media
growth media. Again, this finding parallels with the previous findings by the Stewart

lab in 2020, which found cardiac fibroblasts lacking functional RAGE (RKO; RAGE
knockout mice) had higher migration levels in both non-diabetic RKO and diabetic
RKO fibroblasts when compared to cardiac fibroblasts with intact RAGE (11).
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These findings further complicate the supposed relationship between the

AGE/RAGE signaling cascade and cell differentiation and migration patterns, as the
activated cascade has also been shown to increase cell migration in other studies.
The next experiment examined the role of Rap1a in the cell behavior and
migration process. GTPase Rap1a has been previously found to have a significant
impact on the AGE/RAGE signaling cascade, affecting protein expression and cell
behavior (8). Rap1a was shown to decrease cell migration potentially by regulating
PKC-ζ and ERK1/2 activity in studies by the Stewart lab (8). It was also
demonstrated that Rap1a does overlap the AGE/RAGE cascade to influence
myofibroblast differentiation through direct control of proteins associated with the
cascade (8). However, there is also evidence to prove that Rap1a actually increases
cell migration, aiding in the process of wounding healing is vascular injuries through
rapid regeneration of muscle cells (16). In these experimental trials performed to
analyze the differences in fibroblast migration rates between Rap1a wild type and
Rap1a knockout subjects, the trends that have a potential significance were observed
when Rap1a expression was silenced in the Rap1a knockout subjects, the number of
migrated cells in the wells A1-B7 (low glucose media) tends to stay more consistent
with the number of migrated cells for wells C1-D7 (high glucose media). This

finding aligns with a recent study by the Stewart lab where the lab group found that
cardiac fibroblasts without Rap1a (Rap1a KO) had more migration than fibroblasts
with Rap1a (Rap1a WT) (9). With all of the discrepancies from other sources of

research, it is fair to speculate the correlation between Rap1a presence and cell
migration rates could be attributed to the type of tissue or cell that expressing the
GTPase, as different trends have been determined for each cell type (11). Again,
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Rap1a should be further studied in experimental trials in different forms of tissue to

better gauge its role in myofibroblast differentiation and migration. Finally, another
trend detected in this experiment that parallels the previous study of diabetic and
diabetic RAGE knockout genotype subjects is the general raise in migrated cells as
the media shifts from low glucose media (wells A1-B7) to high glucose media (wells
C1-D7). Hyperglycemic conditions may be responsible for providing a natural
source of AGEs that instigates the AGE/RAGE cascade to a higher degree. As
result, fibroblasts are activated to a highly reactive form, myofibroblast, in which
they exhibit higher rates of migration. Again, these experiments must be repeated to
confirm the reliability of its findings.
The patterns detected in this experiment could point to important leads
related to how the AGE/RAGE signaling cascade impacts fibroblast behavior upon
activation. Cardiac complications related to hyperglycemia and type 2 diabetes
mellitus often result in detrimental ECM remodeling by depositing excess collagen
and matrix protein synthesis (4). High glucose conditions serve as a reservoir for
AGEs to accumulate and form strong, stiffening cross-links with proteins already
present in cardiac tissue (4). Exacerbating the cardiac injury even further, AGEs will
react with their counterpart, RAGE, to produce a wide array of inflammatory

responses, like apoptosis and initiating fibrotic forming factors like ECM
accumulation and cell proliferation (6). Under the activated response of the
AGE/RAGE cascade, fibroblasts will transition to a inflammatory, highly mobile

form that will move towards the site of the injury to form “healing scars” (5).
This experiment sought to investigate these properties by examining how diabetic (db)
subjects behaved compared to diabetic RAGE knockout subjects under the influence of
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an added gradient of AGEs. In this experiment, it is worth noting that high glucose
conditions (wells C1-D7) results in a general increase in cell migration. Also, the
gradient of AGEs from control (0 µL) to experimental values of AGE (7.5, 15, 30, 45,
60 µL) shows a general increase in the experimental conditions. Finally, it appears that
Diabetic RAGE Knockout subject showed an overall greater number of migrated cells.
The latter finding aligns with previous research conducted by the Stewart Lab in 2020;
however, there is no clear explanation for this trend at the moment. In regards, to both
of these findings, repeated experiments must be conducted to confirm and discover
why fibroblasts of different genotypes react this way to exogenous AGEs.
Analyzing the results from the GTPase Rap1a experiment, there were a few
relationships to note: the increase in migration when Rap1a was silenced in RAPKO
subjects. This same conclusion was drawn in a similar study by the Stewart Lab;
however, Rap1a could have different effects on fibroblasts depending on the type of
cell tissues it is acting on. Therefore, future experiments seeking to investigate the role
of Rap1a in fibroblast migration should perform migration tests on fibroblast from
differing tissues to compare and contrast the effects of Rap1a.
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